Home/Pipeline/CAD/INOCA Detection Test

CAD/INOCA Detection Test

Coronary Artery Disease, including Ischemia with No Obstructive Coronary Arteries (INOCA)

Clinical ValidationActive

Key Facts

Indication
Coronary Artery Disease, including Ischemia with No Obstructive Coronary Arteries (INOCA)
Phase
Clinical Validation
Status
Active
Company

About CorVista Health

CorVista Health is an innovative diagnostics company tackling the high rates of misdiagnosis in cardiovascular disease through a proprietary, non-invasive point-of-care platform. By fusing data science with disease biology, the company's technology analyzes subtle physiologic changes to flag risks for multiple conditions simultaneously, aiming to provide answers during a routine doctor's visit. Recent data presentations at major cardiology conferences indicate active clinical validation of its lead test for detecting coronary artery disease, including challenging cases like ischemia with no obstructive coronary arteries (INOCA). As a private, likely pre-revenue company, CorVista is positioning itself to address a massive unmet need in frontline cardiovascular diagnostics.

View full company profile

Therapeutic Areas